GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Teva Pharmaceutical Industries TEVA.TA · ILA

Health Care · Tel Aviv · 🇮🇱 Israel

Compare

13,580.00

+2.11%

Close of 9 Nov 2026, in ILA

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Teva Pharmaceutical Industries — daily TASE:TEVA

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Teva Pharmaceutical Industries on TradingView ↗
Market value
ILS 157.94bn
Last close × shares
Volume
1.4m
Shares, 9 Nov 2026
Price to earnings
34.4

About Teva Pharmaceutical Industries

Its shares trade on Tel Aviv under the ticker TEVA.TA. It has been listed since 1 January 1951. In the fiscal year to 31 December 2025, it reported revenue of $18.68bn and net income of $1.53bn. At that date it held total assets of $40.76bn and shareholders' equity of $7.91bn.

Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Figures and description from our data supplier, not checked against the company's own report.

More about Teva Pharmaceutical Industries →

How it makes its money

Revenue, year to 31 Dec 2024

  • Product [Member] $14.43bn · 87.2%
  • Generics Medicians Including OTC And Biosimilars [Member] $1.94bn · 11.7%
  • Distribution Service [Member] $1.58bn · 9.5%
  • Anda [Member] $1.54bn · 9.3%

Latest on Teva Pharmaceutical Industries

Our reporting

We have not reported on Teva Pharmaceutical Industries yet.

Next results

10 Feb 2027

Due on 10 Feb 2027. Analysts expect earnings of 2.13 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Teva Pharmaceutical Industries's ticker?

Teva Pharmaceutical Industries trades as TEVA.TA on Tel Aviv, under ISIN IL0006290147.

What was Teva Pharmaceutical Industries's last closing price?

13,580.00 on 9 Nov 2026. The figure is in ILA and is never converted.

When does Teva Pharmaceutical Industries next report results?

Results are expected on 10 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.